Net Income

The ad-tech giant posted record revenue for 2025, but a weaker-than-expected forecast for early 2026 sent its stock tumbling. What's next?

MiMedx reports record 2025 sales and a $100M buyback, but faces a major challenge from new Medicare reimbursement rules set to disrupt the wound care market.

With a massive late-stage pipeline and deep pockets, the biotech aims to defeat elusive cancer targets, but soaring costs raise the stakes for pivotal trials.

Amid record financials and new AI breakthroughs, Cadence's CEO will address investors at a key conference to outline the firm's pivotal role in the AI era.

The specialty finance giant posted a stunning turnaround, leveraging tech and a hot U.S. market. Here's how it plans to deliver even more in 2026.

The Kentucky Derby operator posts record revenue and operational earnings, yet a 28% drop in quarterly net income reveals a complex story of growth and challenges.

FTAI Aviation reports a massive profit turnaround and raises its dividend, signaling confidence. But a pivot to power generation may be the real story.

The water midstream leader's inaugural dividend signals financial confidence, but a look at its balance sheet reveals a complex picture of growth and debt.

The enterprise AI firm announced major layoffs after missing revenue targets, but points to strong government contract growth as a path to profitability.

With cash to last until 2027 but mounting losses, Alector stakes its future on its ABC platform and a pivotal Alzheimer's trial milestone.

With record revenue and key battery tech milestones met, Enovix is on the brink of powering smartphones, but manufacturing hurdles and cash burn remain.

With its CFO set to present, Commerce.com faces a key test: convincing investors its AI-driven ecosystem can outpace rivals and fuel future growth.

Quantum firm IonQ shatters revenue goals with $130M in 2025 and moves to acquire a chip foundry, signaling an aggressive push to own the quantum stack.

Fresh off a pivot from fintech, T3 Defense lands $20M to acquire critical suppliers, aiming to fix bottlenecks in America's defense industrial base.

Eton Pharmaceuticals wins landmark FDA approval for DESMODA, a breakthrough liquid drug set to transform care for a rare condition by enabling precise, safe dosing.

Valant's AI Notes Assist now supports 100+ templates, aiming to reduce clinician burnout by fitting into existing workflows, not forcing new ones.

A new alliance aims to solve the GPU utilization puzzle, offering a standardized path for neoclouds to build high-performance AI infrastructure.

New FieldReporter module replaces paper sign-ins with geolocated digital logs, promising real-time data integrity and proactive labor compliance.

A nonprofit is investing millions in a novel program to fast-track academic breakthroughs for neurological diseases from the lab to patients.

Despite lithium market weakness, AMG Critical Materials' adjusted EBITDA surged 40%, showcasing the power of its diversified portfolio and a strategic pivot.